Iwama, Shintaro https://orcid.org/0000-0002-3281-0337
Kobayashi, Tomoko https://orcid.org/0000-0003-3151-1287
Arima, Hiroshi https://orcid.org/0000-0003-3746-1997
Article History
Accepted: 28 November 2024
First Online: 9 January 2025
Competing interests
: S.I. received personal fees from Ono Pharmaceutical Company, Bristol–Myers Squibb, Chugai Pharmaceutical, MSD, AstraZeneca and Merck Biopharma outside this study. T.K. has no competing interests. H.A. received grants from Ono Pharmaceutical Company, MSD, and Chugai Pharmaceutical, as well as personal fees from Ono Pharmaceutical Company, Bristol–Myers Squibb and MSD outside this study.